
Rosacea is a chronic condition — but it’s manageable with the right treatment. Azelaic acid 20% is the best first-line rosacea treatment recommended in clinical guidelines for its anti-inflammatory, antibacterial, and redness-reducing properties. Gentle enough for the most sensitive skin.
Rosacea is a chronic inflammatory condition affecting the central face, driven by dysfunctional immune response, abnormal cathelicidin peptides, Demodex mite involvement, and neurovascular dysregulation. It’s not "just sensitive skin" — it requires targeted treatment that normalises immune signalling and reduces inflammation at the cellular level.

Persistent facial redness, visible blood vessels, flushing episodes on central face. Sun protection is the most effective management tool alongside treatment.

Redness plus acne-like bumps — no comedones. Azelaic acid 20% is first-line treatment for both inflammation and Demodex.

Thickened skin, enlarged pores, rhinophyma — advanced form. Early treatment prevents progression.


The Truth:OTC products soothe temporarily. Prescription azelaic acid treats the underlying inflammatory condition.
Everything you need, nothing you don't. Pick a protocol and start today.
The clinically recommended first-line treatment for rosacea. Azelaic acid 20% addresses inflammation, bumps, and redness in one product. Combined with SPF 50 — the most important management tool for rosacea triggers. This is the evidence-based foundation for rosacea management.

Azelaic Acid Cream 20%
Anti-inflammatory + antibacterial + redness reduction

☀️ SPF 50 Sunscreen
Prevents UV-triggered flares — the #1 rosacea trigger
Required — protects retinoid-sensitised skin
Complete protocol • 2 products

75%
Improvement Rate
Azelaic acid 20% reduced rosacea lesions by up to 75% in 12-week trials.
Thiboutot et al., Journal of the American Academy of Dermatology, 2003

1st Line
Treatment Status
Azelaic acid 20% is recommended first-line treatment by SA clinical guidelines and the National Rosacea Society.
SA clinical guidelines

Category B
Pregnancy Safety
Azelaic acid is one of very few clinical dermatological treatments rated Category B for pregnancy.
FDA Pregnancy Category classification

81%
UV as Trigger
81% of rosacea patients identify sun exposure as most common flare trigger — making SPF the most important management tool.
National Rosacea Society survey data

“Rosacea is a chronic inflammatory condition affecting the central face, driven by dysfunctional immune response, abnormal cathelicidin peptides, Demodex mite involvement, and neurovascular dysregulation. It’s not "just sensitive skin" — it requires targeted treatment that normalises immune signalling and reduces inflammation at the cellular level.”
The most common questions from first-time customers.
Message us and we'll guide you to the right products.
Support hours: Mon–Fri, 9am–5pm SAST
Azelaic acid 20% — the clinically recommended first-line treatment for rosacea. Quality-verified. Gentle. Effective. Start your protocol today.